Direct selection of galactokinase-negative mutants of Candida albicans using 2-deoxy-galactose

Jessica A. Gorman*, John W. Gorman, Y. Koltin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The galactose analogue 2-deoxy-galactose (2DG) has been widely used to select for mutations in the gene encoding the galactose pathway enzyme galactokinase (GalK). We have tested the effect of 2DG on Candida albicans to see if it could be used to obtain GalK- mutants in this diploid asexual yeast. 2DG was shown to be toxic to wild-type cells. Enzyme assays demonstrated that 2DG can induce GalK as efficiently as galactose. Examination of the initital rate of galactose uptake indicated that the galactose transport system is constitutive. 2DG-resistant mutants were isolated from mutagenized cultures and shown to have very low levels of GalK activity. The potential genetic applications of this system of direct mutant selection are discussed.

Original languageEnglish
Pages (from-to)203-206
Number of pages4
JournalCurrent Genetics
Issue number3
StatePublished - Mar 1992


  • Galactokinase
  • Mutant selection
  • Yeast


Dive into the research topics of 'Direct selection of galactokinase-negative mutants of Candida albicans using 2-deoxy-galactose'. Together they form a unique fingerprint.

Cite this